Clinical Trials Browser

Phase 2 × Carcinoma, Renal Cell × Standard of Care × Clear all

NCT03075423 2025-09-26

Randomized Phase-II Study of Nivolumab Plus Ipilimumab vs. Standard of Care in Untreated and Advanced Non-clear Cell RCC

Phase 2 Completed

Carcinoma, Renal Cell